Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

COVID-19 may harm male fertility and damage the reproductive system.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Social media data can help track and predict COVID-19 symptoms and trends.

COVID-19 can cause skin problems in children.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Mice with a virus similar to COVID-19 had skin damage, but a special treatment helped repair it.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

COVID-19 may worsen hair loss, but treatments like minoxidil can help.

Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

Red laser therapy helped regrow hair in an alopecia areata patient within 21 days.

Most Facebook posts about hair loss treatments are promotional and not medically supported, with better quality information found on YouTube.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

Protein analysis shows aging changes in scalp cell types from women.

Skin aging and cancer development are influenced by the competition between stem cells.